nach oben

Reactions Weekly

Erschienen in:

01.05.2019 | Case report

Atorvastatin

Increased hepatic transaminases level: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a study of 90 patients, 1 patient [age and sex not stated] was described, who developed increased hepatic transaminases level during treatment with atorvastatin for ST-segment elevation myocardial infarction (STEMI). The patient, who had STEMI, started receiving atorvastatin 80mg per day [route not stated]. Subsequently, the patient's hepatic transaminases level increased to three or more times than the normal threshold values [time to reaction onset and outcome not stated]. …

Oleinikov V, et al. Laboratory monitoring of efficacy and safety of atorvastatin high doses in myocardial infarction with ST-segment elevation. European Heart Journal 39 (Suppl. 1): 957 (plus poster) abstr. P4641, Aug 2018. Available from: URL: https://doi.org/10.1093/eurheartj/ehy563.P4641 [abstract] -Russia

Titel: Atorvastatin
Increased hepatic transaminases level: case report
Publikationsdatum: 01.05.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-61558-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Atorvastatin

Increased hepatic transaminases level: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Plasma

Difluprednate

Prednisone

Paracetamol

Multiple drugs

Etanercept